ATAD2 and cancer: We explore the role of the 8q24 amplification in endometrial cancer through integrative genomic analyses of primary and metastatic endometrial cancers with comprehensive clinical data, and identify ATAD2 as an additional target of the 8q24 amplification in these cancers.